Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Nov 15, 2017
Document Date
Nov 13, 2017
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS INC
Filer
Cantley Lewis Clayton Jr.